A sign for the Food and Drug Administration is displayed outside their offices in Silver Spring, Md., on Dec. 10, 2020. (AP Photo/Manuel Balce Ceneta, File)
The life-saving overdose reversal agent Narcan is one step closer to being easily accessed by the general public.
The Food and Drug Administration's board of independent advisors voted to make the nasal spray available for over-the-counter purchasing.
"There is no reason to keep this as a prescription, let's get it out there and save some lives," Elizabeth Coykendall, a temporary voting member on the FDA's advisory board and paramedic at PM Pediatrics in Raleigh, North Carolina, told CNBC.
A final decision has not been made by the agency but they are expected to have a final answer by March 29. Emergent BioSolutions, the maker of Narcan, said the spray would be available for purchase by late summer if it receives FDA approval.
All 50 states currently offer a generic version of Narcan known as Naloxone, and it is already being sold over-the-counter after a sharp rise in overdose deaths in recent years. People seeking the treatment do not have to have a prescription.
"Allowing it to be sold over-the-counter in the same manner in every state really clears uop some confusion and hopefully clears up some of that red tape," Dr Kirk Evoy, a clinical associate professor of pharmacotherapy a the University of Texas at Austin, told CNN.
If the FDA does remove Narcan from its list of prescribed treatments, it could become available in places outside of pharmacies like vending machines, supermarkets and convenience stores.
Heila Technologies, a startup that develops hardware and software to integrate renewables and batteries on a microgrid, is helping to power the first clean energy microgrid for Auto Mercado, a top supermarket chain in Costa Rica. The plant will reduce 20 tons of CO2 emissions per year. Heila Technologies CEO Francisco Morocz joins Cheddar Climate to discuss.
The U.S. has a million-ton problem: each year, hundreds of pounds of plastic waste are produced per person, and that leads to close to 2 million tons of that waste leaking into the environment. Eight million tons end up in the ocean, where it hinders marine life, damages ecosystems, and impacts industry. But in recent years, Congress has introduced measures including the Save our Seas act to try to mitigate the issue and turn our plastic problem around. Sen. Chris Murphy (D-CT) joins Cheddar Climate to discuss why the U.S. is the top global polluter of plastic, what Congress is doing to try to fix the issue, and more.
Daniel Huppmann, researcher at International Institute for Applied Systems Analysis, joins Cheddar Climate, where he explains how the global economy could be 2% bigger by 2100 if the world can hold global warming below 1.5°C.
While the World Health Organization strongly advises against a COVID-19 vaccine mandate, national and local governments are moving to make inoculations compulsory. Cheddar News speaks with Dr. Joel Zinberg of the Competitive Enterprise Institute on the issue.
Cheddar breaks down the challenges of plastic recycling and what one company is doing to help offset the negative environmental impact of single-use plastics.
Earlier this year, JetBlue flew its inaugural flight into the United Kingdom. It was a game changer — not only did the airline enter the transatlantic market, but the plane that completed the flight was a single-aisle jet. For decades, flying the distance was synonymous with jumbo jets, but today narrow-body aircraft are now proving they are up for the task — and maybe even the best option. In this episode, Cheddar examines why airlines are betting on narrow-body aircraft.
Carlo and Baker discuss the sweeping new vaccine mandate in NYC that will target all private businesses. Plus, Trump's media venture gets its CEO and more.
Humans are scientifically the most successful species in the history of planet earth. And for this we can thank our opposable thumbs, proportionally large brains, and our upright posture. But for all our anatomical wonders, we still have some pretty major flaws.